The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study

dc.contributor.authorHaghighat, Roxanna
dc.contributor.authorToska, Elona
dc.contributor.authorBungane, Nontuthuzelo
dc.contributor.authorCluver, Lucie
dc.date.accessioned2021-10-11T08:58:25Z
dc.date.available2021-10-11T08:58:25Z
dc.date.issued2021-01-13
dc.date.updated2021-01-17T04:08:29Z
dc.description.abstractBackground Little evidence exists to comprehensively estimate adolescent viral suppression after initiation on antiretroviral therapy in sub-Saharan Africa. This study examines adolescent progression along the HIV care cascade to viral suppression for adolescents initiated on antiretroviral therapy in South Africa. Methods All adolescents ever initiated on antiretroviral therapy (n=1080) by 2015 in a health district of the Eastern Cape, South Africa, were interviewed in 2014–2015. Clinical records were extracted from 52 healthcare facilities through January 2018 (including records in multiple facilities). Mortality and loss to follow-up rates were corrected for transfers. Predictors of progression through the HIV care cascade were tested using sequential multivariable logistic regressions. Predicted probabilities for the effects of significant predictors were estimated by sex and mode of infection. Results Corrected mortality and loss to follow-up rates were 3.3 and 16.9%, respectively. Among adolescents with clinical records, 92.3% had ≥1 viral load, but only 51.1% of viral loads were from the past 12 months. Adolescents on ART for ≥2 years (AOR 3.42 [95%CI 2.14–5.47], p< 0.001) and who experienced decentralised care (AOR 1.39 [95%CI 1.06–1.83], p=0.018) were more likely to have a recent viral load. The average effect of decentralised care on recent viral load was greater for female (AOR 2.39 [95%CI 1.29–4.43], p=0.006) and sexually infected adolescents (AOR 3.48 [95%CI 1.04–11.65], p=0.043). Of the total cohort, 47.5% were recorded as fully virally suppressed at most recent test. Only 23.2% were recorded as fully virally suppressed within the past 12 months. Younger adolescents (AOR 1.39 [95%CI 1.06–1.82], p=0.017) and those on ART for ≥2 years (AOR 1.70 [95%CI 1.12–2.58], p=0.013) were more likely to be fully viral suppressed. Conclusions Viral load recording and viral suppression rates remain low for ART-initiated adolescents in South Africa. Improved outcomes for this population require stronger engagement in care and viral load monitoring.en_US
dc.identifier.apacitationHaghighat, R., Toska, E., Bungane, N., & Cluver, L. (2021). The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study. <i>BMC Infectious Diseases</i>, 21(Article number: 60), http://hdl.handle.net/11427/35146en_ZA
dc.identifier.chicagocitationHaghighat, Roxanna, Elona Toska, Nontuthuzelo Bungane, and Lucie Cluver "The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study." <i>BMC Infectious Diseases</i> 21, Article number: 60. (2021) http://hdl.handle.net/11427/35146en_ZA
dc.identifier.citationHaghighat, R., Toska, E., Bungane, N. & Cluver, L. 2021. The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study. <i>BMC Infectious Diseases.</i> 21(Article number: 60) http://hdl.handle.net/11427/35146en_ZA
dc.identifier.ris TY - Journal Article AU - Haghighat, Roxanna AU - Toska, Elona AU - Bungane, Nontuthuzelo AU - Cluver, Lucie AB - Background Little evidence exists to comprehensively estimate adolescent viral suppression after initiation on antiretroviral therapy in sub-Saharan Africa. This study examines adolescent progression along the HIV care cascade to viral suppression for adolescents initiated on antiretroviral therapy in South Africa. Methods All adolescents ever initiated on antiretroviral therapy (n=1080) by 2015 in a health district of the Eastern Cape, South Africa, were interviewed in 2014–2015. Clinical records were extracted from 52 healthcare facilities through January 2018 (including records in multiple facilities). Mortality and loss to follow-up rates were corrected for transfers. Predictors of progression through the HIV care cascade were tested using sequential multivariable logistic regressions. Predicted probabilities for the effects of significant predictors were estimated by sex and mode of infection. Results Corrected mortality and loss to follow-up rates were 3.3 and 16.9%, respectively. Among adolescents with clinical records, 92.3% had ≥1 viral load, but only 51.1% of viral loads were from the past 12 months. Adolescents on ART for ≥2 years (AOR 3.42 [95%CI 2.14–5.47], p< 0.001) and who experienced decentralised care (AOR 1.39 [95%CI 1.06–1.83], p=0.018) were more likely to have a recent viral load. The average effect of decentralised care on recent viral load was greater for female (AOR 2.39 [95%CI 1.29–4.43], p=0.006) and sexually infected adolescents (AOR 3.48 [95%CI 1.04–11.65], p=0.043). Of the total cohort, 47.5% were recorded as fully virally suppressed at most recent test. Only 23.2% were recorded as fully virally suppressed within the past 12 months. Younger adolescents (AOR 1.39 [95%CI 1.06–1.82], p=0.017) and those on ART for ≥2 years (AOR 1.70 [95%CI 1.12–2.58], p=0.013) were more likely to be fully viral suppressed. Conclusions Viral load recording and viral suppression rates remain low for ART-initiated adolescents in South Africa. Improved outcomes for this population require stronger engagement in care and viral load monitoring. DA - 2021-01-13 DB - OpenUCT DP - University of Cape Town IS - Article number: 60 J1 - BMC Infectious Diseases KW - Adolescent KW - HIV KW - Antiretroviral therapy KW - South Africa KW - Care cascade KW - Continuum of care LK - https://open.uct.ac.za PY - 2021 T1 - The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study TI - The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study UR - http://hdl.handle.net/11427/35146 ER - en_ZA
dc.identifier.urihttps://doi.org/10.1186/s12879-020-05742-9
dc.identifier.urihttp://hdl.handle.net/11427/35146
dc.identifier.vancouvercitationHaghighat R, Toska E, Bungane N, Cluver L. The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study. BMC Infectious Diseases. 2021;21(Article number: 60) http://hdl.handle.net/11427/35146.en_ZA
dc.language.isoenen_US
dc.language.rfc3066en
dc.publisher.departmentCentre for Social Science Research(CSSR)en_US
dc.publisher.facultyFaculty of Humanitiesen_US
dc.rights.holderThe Author(s)
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.sourceBMC Infectious Diseasesen_US
dc.source.journalissueArticle number: 60en_US
dc.source.journalvolume21en_US
dc.source.urihttps://bmcinfectdis.biomedcentral.com/
dc.subjectAdolescenten_US
dc.subjectHIVen_US
dc.subjectAntiretroviral therapyen_US
dc.subjectSouth Africaen_US
dc.subjectCare cascadeen_US
dc.subjectContinuum of careen_US
dc.titleThe HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort studyen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
12879_2020_Article_5742.pdf
Size:
851.95 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Collections